Lifetime Attributable Risk for Breast Cancer Induced by High-resolution Computed Tomography during COVID-19 Pandemic
According to our research, the risk of potential breast cancer should not be overlooked. It is advised to use the ultra-low-dose protocol over the low-dose in HRCT. Physicians, pulmonologists, and infectious disease specialists are advised to avoid unnecessary and repeated requests for chest HRCT in a short period.
Authors
- Jafar Hassanzadeh
- Alireza Mirahmadizadeh (ORCID: https://orcid.org/0000-0002-2259-4984)
- Rezvan Ravanfar Haghighi (ORCID: https://orcid.org/0000-0001-5375-5755)
- Mehrzad Lotfi (ORCID: https://orcid.org/0000-0001-5192-4930)
- Roya Sahebi
Institutions
- Shiraz University of Medical Sciences (IR)
Publication Details
- Journal
- Journal of Family & Reproductive Health
- Published
- 2024-12-30
- DOI
- https://doi.org/10.18502/jfrh.v18i4.17429
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Shiraz University of Medical Sciences
- Shiraz University